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Supplemental figure legends 
 
Fig. 1 supplemental: Dose response of cytokine induction after a single R848 injection 
in vivo 
Mice were injected with varying doses of R848 subcutaneously (2.5 - 20 µg). Two, 4 and 8 h 
p.i. serum was analyzed for cytokines by ELISA. Sera of three mice were pooled for analysis. 
 
Fig. 2 supplemental: Fractionated R848 tumor therapy is similar in efficacy to a DC 
vaccine combined with CpG 
Mice (n = 4 to 5 per group) were inoculated with 2.5 x 105 CT26 colon carcinoma cells s.c. on 
day 0. On days 7, 11, 15 and 19 (arrows) mice were treated as follows: Controls were left 
untreated, the R848 group obtained 20 µg R848 four times per treatment cycle as indicated 
by the schedule below the graph. For DC + CpG 2 x 105 tumor-loaded DC per mouse were 
applied contralaterally followed by treatment with 200 µg CpG. Asterisks (**, p < 0.01; ***, p < 
0.001) indicate significant differences to the untreated group. 
 
Fig. 3 supplemental: Cox1/2 inhibitors do not affect tolerance induction 
Bone marrow cells were stimulated for 24 h with 0.1 µg/ml R848 or left unstimulated in the 
presence of increasing concentrations of Cox1/2 inhibitors, washed and restimulated with 
0.1 µg/ml R848. Asterisks (*, p < 0.05; **, p < 0.01; ***, p < 0.001) indicate significant 
differences between cells that were prestimulated with R848 (black bars) and cells that were 
not prestimulated (white bars). 'bdl' indicates below detection limit. Data are representative of 
two independent experiments. 
 
Fig. 4 supplemental: R848 pretreatment in the ng/ml scale does not induce tolerance 
Primary bone marrow cells (4 x 105 per well) were stimulated for 24 h with indicated 
concentrations (in ng/ml) of R848, washed and restimulated for 6 h with 1µg/ml R848. 
Cytokine levels were determined by ELISA. Secretion of cytokines was normalized to cells 
that were not prestimulated. Asterisks (*, p < 0.05; **, p < 0.01; ***, p < 0.001) indicate 
Bourquin, C., Hotz, C. et. al.: R848 tolerance  7/15/11 
2 
significant differences between cells that were prestimulated with R848 (black bars) and cells 
that were not prestimulated (white bars). 
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